BRD-K85925969-001-16-6
HELA
maintaining cell culture
L1000-Phase2
cervical adenocarcinoma
datapackage.zip
LINCS
L1000 LINCS DCIC REP.A020 HELA 24H E18 zalcitabine 0.04um.tsv.gz
uterine cervix
Label
Description
A Substance
A 160 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project